HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Nelson, M. Articles by Titball, R. W Search for Related Content PubMed PubMed Citation Articles by Nelson, M. Articles by Titball, R. W Agricola Articles by Nelson, M. Articles by Titball, R. W

Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis

Defence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK

Correspondence Michelle Nelson mnelson{at}dstl.gov.uk

Received June 3, 2004
Accepted August 26, 2004

Burkholderia pseudomallei is the causative agent of melioidosis, which is a major cause of morbidity and mortality in endemic regions. Currently there is no human vaccine against melioidosis. In this study, LPS or capsular polysaccharide was used to immunize BALB/c mice. The different polysaccharide antigens induced antibody responses. Mice vaccinated with LPS developed predominantly IgM and IgG3 responses. Contrastingly, mice vaccinated with capsular polysaccharide developed a predominantly IgG2b response. After immunization, mice were challenged by the intra-peritoneal route and an increased mean time to death was observed compared with unvaccinated controls. Immunization with LPS provided an optimal protective response. Mice challenged by the aerosol route showed a small increase in the mean time to death compared with the unvaccinated controls. The passive transfer of antigen from immunized into naïve mice provided protection against a subsequent challenge. This study is the first time antigens protective by active immunization have been identified and suggests that polysaccharides have potential as vaccine candidates against melioidosis.

This article has been cited by other articles:

				D. N. Harland, K. Chu, A. Haque, M. Nelson, N. J. Walker, M. Sarkar-Tyson, T. P. Atkins, B. Moore, K. A. Brown, G. Bancroft, et al. Identification of a LolC Homologue in Burkholderia pseudomallei, a Novel Protective Antigen for Melioidosis Infect. Immun., August 1, 2007; 75(8): 4173 - 4180. [Abstract] [Full Text] [PDF]

				M. Sarkar-Tyson, J. E. Thwaite, S. V. Harding, S. J. Smither, P. C. F. Oyston, T. P. Atkins, and R. W. Titball Polysaccharides and virulence of Burkholderia pseudomallei J. Med. Microbiol., August 1, 2007; 56(8): 1005 - 1010. [Abstract] [Full Text] [PDF]

				Y.-S. Chen, Y.-S. Hsiao, H.-H. Lin, Y. Liu, and Y.-L. Chen CpG-Modified Plasmid DNA Encoding Flagellin Improves Immunogenicity and Provides Protection against Burkholderia pseudomallei Infection in BALB/c Mice Infect. Immun., March 1, 2006; 74(3): 1699 - 1705. [Abstract] [Full Text] [PDF]